|
MechanismNK1R antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date11 Jan 2008 |
100 Clinical Results associated with SteriScience, Inc.
0 Patents (Medical) associated with SteriScience, Inc.
100 Deals associated with SteriScience, Inc.
100 Translational Medicine associated with SteriScience, Inc.